NCT06617390 - A Study of Real-world Treatment Patterns and Outcomes in Chinese Advanced NSCLC Patients Who Previously Received at Least 2 Line Treatments | Biotech Hunter

Enrollment

1,041

Participants

Timeline

Start Date

August 15, 2024

Primary Completion Date

January 26, 2025

Study Completion Date

July 30, 2025

Conditions

Non-small Cell Lung Cancer (NSCLC)

Interventions

OTHER

No drug

This is a non-interventional study and no study drug will be provided.

Trial Locations (6)

Beijing Cancer Hospital, Beijing

The First Affiliated Hospital of Fujian Medical University, Fuzhou

Sun Yat-sen University Cancer Center, Guangzhou

Affiliated Cancer Hospital of Shandong First Medical University, Jinan

Liaoning Cancer Hospital & Institute, Shenyang

The First Affiliated Hospital of Soochow University, Suzhou